cost of cancer
economic implications of cancer
cancer care costs
complete removal of cancer
lead cancer indication
Cerenkov Imaging
Surgical Margin Assessment Cancer
health outcomes
health economic impact
wide range of major cancer indications
Cerenkov Luminescence Imaging
negative health ramifications
leading public health challenge
costly re-operations
breakthrough imaging modality
Europe
molecular imaging camera
surgeons
technology
growing economic challenge
year
clinical efficacy of LightPath
company’s growth
single operation
treatment costs
company’s ambitious sales
multi-centre clinical trial
marketing strategy
adjuvant therapies
real time intraoperative analysis of cancerous tissue
strategic target territories
dramatic reduction
technologies
compelling business opportunity
healthcare providers
potential
primary treatments
innovative solution
Lightpoint Medical
project
tools
half
disease
population
CerISMA
Surgery
device
Forecasts
lifetime
cases
continent